Literature DB >> 10444158

Intensive treatment for multiple myeloma: where do we stand?

H M Lokhorst1, P Sonneveld, L F Verdonck.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10444158     DOI： 10.1046/j.1365-2141.1999.01406.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  2 in total

1.  CD28-mediated regulation of multiple myeloma cell proliferation and survival.

Authors:  Nizar J Bahlis; Anne M King; Despina Kolonias; Louise M Carlson; Hong Yu Liu; Mohamad A Hussein; Howard R Terebelo; Gerald E Byrne; Bruce L Levine; Lawrence H Boise; Kelvin P Lee
Journal:  Blood       Date:  2007-02-20       Impact factor: 22.113

2.  Characterization of cyclin E expression in multiple myeloma and its functional role in seliciclib-induced apoptotic cell death.

Authors:  Liat Josefsberg Ben-Yehoshua; Katia Beider; Avichai Shimoni; Olga Ostrovsky; Michal Samookh; Amnon Peled; Arnon Nagler
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.